Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial
Authors
Keywords
Antiretroviral therapy, Death rates, HIV, Viral load, HIV infections, Reverse transcriptase inhibitors, Adverse events, Inflammation
Journal
PLOS MEDICINE
Volume 15, Issue 12, Pages e1002706
Publisher
Public Library of Science (PLoS)
Online
2018-12-05
DOI
10.1371/journal.pmed.1002706
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Persistent High Burden of Advanced HIV Disease Among Patients Seeking Care in South Africa’s National HIV Program: Data From a Nationwide Laboratory Cohort
- (2018) Sergio Carmona et al. CLINICAL INFECTIOUS DISEASES
- Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial
- (2018) Frank A Post et al. CLINICAL INFECTIOUS DISEASES
- Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion
- (2017) OT Stirrup et al. HIV MEDICINE
- Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa
- (2017) James Hakim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort study
- (2017) Samantha R. Kaplan et al. PLOS MEDICINE
- Integrase inhibitors in late pregnancy and rapid HIV viral load reduction
- (2016) Lisa Rahangdale et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015
- (2016) Duncan Churchill et al. HIV MEDICINE
- Different impact of raltegravir versus efavirenz on CD4/CD8 ratio recovery in HIV-infected patients
- (2016) Sergio Serrano-Villar et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy
- (2016) Andrew J. Prendergast et al. JOURNAL OF INFECTIOUS DISEASES
- Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s
- (2015) Theodoros Kelesidis et al. CLINICAL INFECTIOUS DISEASES
- Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial
- (2014) JE Lake et al. HIV MEDICINE
- Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies
- (2014) Andrew Boulle et al. PLOS MEDICINE
- Differential penetration of raltegravir throughout gastrointestinal tissue
- (2013) Kristine B. Patterson et al. AIDS
- Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs
- (2013) Eleanor M. P. Wilson et al. IMMUNOLOGICAL REVIEWS
- Increase in 2–Long Terminal Repeat Circles and Decrease in D-dimer After Raltegravir Intensification in Patients With Treated HIV Infection: A Randomized, Placebo-Controlled Trial
- (2013) Hiroyu Hatano et al. JOURNAL OF INFECTIOUS DISEASES
- Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study
- (2013) Francois Raffi et al. LANCET
- Gastrointestinal-associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus non-nucleoside reverse transcriptase inhibitor-based regimens
- (2012) David M. Asmuth et al. AIDS
- The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients
- (2012) Alejandro Vallejo et al. AIDS
- Mortality in the Year Following Antiretroviral Therapy Initiation in HIV-Infected Adults and Children in Uganda and Zimbabwe
- (2012) A. Sarah Walker et al. CLINICAL INFECTIOUS DISEASES
- Long-term Treatment With Raltegravir or Efavirenz Combined With Tenofovir/Emtricitabine for Treatment-Naive Human Immunodeficiency Virus-1–Infected Patients: 156-Week Results From STARTMRK
- (2011) Jürgen K. Rockstroh et al. CLINICAL INFECTIOUS DISEASES
- Early Mortality in Adults Initiating Antiretroviral Therapy (ART) in Low- and Middle-Income Countries (LMIC): A Systematic Review and Meta-Analysis
- (2011) Amita Gupta et al. PLoS One
- Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007
- (2010) Morna Cornell et al. AIDS
- HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
- (2010) Maria J Buzón et al. NATURE MEDICINE
- Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings
- (2008) Graeme Meintjes et al. LANCET INFECTIOUS DISEASES
- Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
- (2008) Lewis H Kuller et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation